The aim of this research is to study the etiology, the clinical picture, the management, the complications and the outcomes of necrotic pancreatitis in children. Currently, there is a significant number of errors in the early diagnosis of AP in children associated with the complexity of differential diagnosis, which leads to the untimely verification of the correct diagnosis and, consequently, to incorrect treatment tactics, which could be accompanied by an increase in the severe forms of the disease and an increase in mortality.
Acute pancreatitis (AP) is an acute inflammatory disease of the exocrine pancreas. Clinical manifestations vary from mild abdominal discomfort to metabolic disorders, sepsis, fluid sequestration, multiple organ failure and death. According to the international data, the annual incidence of AP in children is 3-13 cases per 100,000 people, but in recent years, there has been an increase in the incidence of this pathology. Necrotic pancreatitis in children accounts for up to 25-30% of the cases of all forms of AP. Despite the successes achieved in the diagnosis and treatment of AP, the mortality rate for this pathology is up to 5%, according to various authors. In addition, given the varying degrees of the prevalence of the destructive process in the pancreas and the parapancreatic tissue, the choice of surgical treatment still remains a subject of discussion. The treatment of moderately severe (MSAP) and severe (SAP) necrotic pancreatitis is a complex task due to the variety of causes of the disease, the incompletely understood pathogenesis and the uncertainty in predicting the results. Paralytic ileus with the development of intestinal failure is the main pathogenetic factor in the development of a septic condition in AP, but there is tendency of insufficient attention being paid to this fact in pediatric practice, which determines the lack of a unified approach to the treatment of intestinal failure syndrome.
Study Type
OBSERVATIONAL
Enrollment
102
Only data from the patient file.
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
Moscow, Moscow Oblast, Russia
the frequency of occurrence of various etiologic causes of necrotizing pancreatitis in children
based on the study, the most common causes of necrotizing pancreatitis in children will be identified
Time frame: From enrollment to the end of treatment (2 month)
The duration from the onset of the disease to the start of the treatment
Time frame: from the onset of the disease to the end of treatment (up to 20 weeks)
The duration of hospital stay
the effect of each risk factor on the duration of hospital stay
Time frame: from admission to hospital until the end of treatment (up to 8 weeks)
The length of ICU stay
Time frame: During ICU stay (up to 60 days)
The effect of comorbidities on the severity of the disease
Time frame: from admission to hospital until the end of treatment (up to 8 weeks)
Intestinal failure
the effect of Intestinal failure on the duration of hospital stay
Time frame: from admission to hospital until the end of treatment (up to 8 weeks)
Paralytic ileus
the effect of paralytic ileus on the severity of acute pancreatitis and the length of hospital stay
Time frame: from admission to hospital until the end of treatment (up to 8 weeks)
Mortality
Time frame: from admission to hospital until the end of treatment (up to 20 weeks)
Enzymatic parapancreatitis
the effect on severity of the disease and the outcome
Time frame: from admission to hospital until the end of treatment (up to 10 weeks)
Purulent-necrotic parapancreatitis
the effect on severity of the disease and the outcome
Time frame: from admission to hospital until the end of treatment (up to 20 weeks)
Biliary obstruction
Time frame: from admission to hospital until the end of treatment (up to 20 weeks)
Surgical interventions
Time frame: from admission to hospital until the end of treatment (up to 20 weeks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.